Thermo Fisher Scientific Inc.
TMO· NYSE
Source filing unavailable
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $6.05B | $4.95B | $4.65B | $4.49B |
| EPS Diluted | $1.30 | $1.59 | $1.50 | $1.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR